Courthouse Steps Decision: FDA v. AHM
![Courthouse Steps Decision: FDA v. AHM](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/f9b2c13c721ceeb90cab6bba4e781bdd.jpg)
Sign up for free
Listen to this episode and many more. Enjoy the best podcasts on Spreaker!
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
In November 2022, the Alliance Defending Freedom (ADF) filed a federal lawsuit in the U.S. District Court for the Northern District of Texas, Amarillo Division, against the United States Food...
show moreThe suit challenged the FDA’s 2000 decision to legalize mifepristone and misoprostol, two drugs often used in conjunction as chemical abortifacients, and regulation of the drugs thereafter. The case rose through the Fifth Circuit, which ruled in favor of AHM. The Supreme Court granted cert, heard Oral Argument on March 26, 2024, and on June 13, 2024, issued a 9-0 decision holding the plaintiffs lacked standing to challenge the FDA.
Join us for a Courthouse Steps Decision program, where we will analyze this decision and its possible ramifications.
Featuring:
Adam Unikowsky, Partner, Jenner & Block LLP
Megan M. Wold, Partner, Cooper & Kirk
(Moderator) Prof. Teresa Stanton Collett, Professor and Director, Prolife Center, University of St. Thomas School of Law
Information
Author | The Federalist Society |
Website | - |
Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company